Mestag Therapeutics ("Mestag"), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded ...
CAMBRIDGE, United Kingdom, Nov. 13, 2024 (GLOBE NEWSWIRE ... in solid tumors and their role in driving improved patient outcomes; the M402 program, targeting a stromal checkpoint to dampen down the ...
Radiotherapy-activated NBTXR3 is being evaluated across multiple solid tumor indications as a single agent or in combination with anti-PD-1 immune checkpoint inhibitors ... The Company has ...
Mr. Olalekan Oluwadairo, Head of School at Pampers Private School, Lekki, explained that the new Lekki campus features modern classrooms equipped with the required technology, conducive learning ...
Check Point met analyst expectations in the third quarter of 2024 but failed to excite investors. Investors hoped for Check Point to gain from CrowdStrike's expensive July outage, but results didn ...